These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6751113)

  • 1. Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine.
    Raventos-Suarez C; Pollack S; Nagel RL
    Am J Trop Med Hyg; 1982 Sep; 31(5):919-22. PubMed ID: 6751113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reappraisal of the effects of iron and desferrioxamine on the growth of Plasmodium falciparum 'in vitro': the unimportance of serum iron.
    Peto TE; Thompson JL
    Br J Haematol; 1986 Jun; 63(2):273-80. PubMed ID: 3521714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desferrioxamine suppresses Plasmodium falciparum in Aotus monkeys.
    Pollack S; Rossan RN; Davidson DE; Escajadillo A
    Proc Soc Exp Biol Med; 1987 Feb; 184(2):162-4. PubMed ID: 3543939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria.
    Stahel E; Mazier D; Guillouzo A; Miltgen F; Landau I; Mellouk S; Beaudoin RL; Langlois P; Gentilini M
    Am J Trop Med Hyg; 1988 Sep; 39(3):236-40. PubMed ID: 3052118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.
    Pattanapanyasat K; Thaithong S; Kyle DE; Udomsangpetch R; Yongvanitchit K; Hider RC; Webster HK
    Cytometry; 1997 Jan; 27(1):84-91. PubMed ID: 9000589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Plasmodium falciparum growth by a synthetic iron chelator.
    Iheanacho EN; Samuni A; Avramovici-Grisaru S; Sarel S; Spira DT
    Trans R Soc Trop Med Hyg; 1990; 84(2):213-6. PubMed ID: 2202102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-dependent effect of deferoxamine on growth of Plasmodium falciparum in vitro.
    Whitehead S; Peto TE
    Blood; 1990 Sep; 76(6):1250-5. PubMed ID: 2205310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures.
    Loyevsky M; Sacci JB; Boehme P; Weglicki W; John C; Gordeuk VR
    Exp Parasitol; 1999 Feb; 91(2):105-14. PubMed ID: 9990337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria pigment and extracellular iron. Possible target for iron chelating agents.
    van Zyl RL; Havlik I; Hempelmann E; MacPhail AP; McNamara L
    Biochem Pharmacol; 1993 Apr; 45(7):1431-6. PubMed ID: 8471067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin.
    Fritsch G; Sawatzki G; Treumer J; Jung A; Spira DT
    Exp Parasitol; 1987 Feb; 63(1):1-9. PubMed ID: 3542546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators.
    Loyevsky M; John C; Dickens B; Hu V; Miller JH; Gordeuk VR
    Mol Biochem Parasitol; 1999 Jun; 101(1-2):43-59. PubMed ID: 10413042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial effect of iron chelators.
    Gordeuk VR; Loyevsky M
    Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth inhibition of Plasmodium falciparum involving carbon centered iron-chelate radical (L., X-)-Fe(III) based on pyridoxal-betaine. A novel type of antimalarials active against chloroquine-resistant parasites.
    Iheanacho EN; Sarel S; Samuni A; Avramovici-Grisaru S; Spira DT
    Free Radic Res Commun; 1991; 15(1):1-10. PubMed ID: 1663064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of zinc-desferrioxamine on Plasmodium falciparum in culture.
    Chevion M; Chuang L; Golenser J
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1902-5. PubMed ID: 7486946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 14C-desferrioxamine B: uptake into erythrocytes infected with Plasmodium falciparum.
    Fritsch G; Jung A
    Z Parasitenkd; 1986; 72(6):709-13. PubMed ID: 3541423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of iron and desferrioxamine on the growth of Plasmodium falciparum in vitro.
    Pollack S
    Br J Haematol; 1987 Feb; 65(2):256-7. PubMed ID: 3548800
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of antimalarial effect of ICL670A on in vitro cultures of Plasmodium falciparum.
    Goudeau C; Loyevsky M; Kassim OO; Gordeuk VR; Nick H
    Br J Haematol; 2001 Dec; 115(4):918-23. PubMed ID: 11843826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined effect of iron chelators and classical antimalarials on the in-vitro growth of Plasmodium falciparum.
    van Zyl RL; Havlik I; Monteagudo FS
    J Antimicrob Chemother; 1992 Sep; 30(3):273-8. PubMed ID: 1452491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mechanism of action of desferrioxamine and 2,2'-bipyridyl on inhibiting the in vitro growth of Plasmodium falciparum (FCR 3 strain).
    Jairam KT; Havlik I; Monteagudo FS
    Biochem Pharmacol; 1991 Sep; 42(8):1633-4. PubMed ID: 1930289
    [No Abstract]   [Full Text] [Related]  

  • 20. Iron chelation as a chemotherapeutic strategy for falciparum malaria.
    Gordeuk VR; Thuma PE; Brittenham GM; Biemba G; Zulu S; Simwanza G; Kalense P; M'Hango A; Parry D; Poltera AA
    Am J Trop Med Hyg; 1993 Feb; 48(2):193-7. PubMed ID: 8447522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.